A similar study found that higher levels of Aβ42 and total tau in aMCI patients were associated with lower episodic verbal memory performance at baseline and cognitive decline over the course of follow up (average follow-up period of 1.5 years) [37]. The gene discussed is MAPT; the disease is Mental deterioration.